All Stories

  1. Therapeutic anti‐amyloid β antibodies cause neuronal disturbances

    Article • Alzheimer s & Dementia, December 2022, Wiley

    MOURAD TAYEBI

  2. A sequential deposition of amyloid beta oligomers, plaques and phosphorylated tau occurs throughout life in the canine retina

    Article • Ageing and Neurodegenerative Diseases, January 2022, OAE Publishing

    MOURAD TAYEBI

  3. Treatment of microglia with Anti-PrP monoclonal antibodies induces neuronal apoptosis in vitro

    Article • Heliyon, December 2021, Elsevier

    MOURAD TAYEBI

  4. Case Report: Synucleinopathy Associated With Phalaris Neurotoxicity in Sheep

    Article • Frontiers in Veterinary Science, October 2021, Frontiers

    MOURAD TAYEBI

  5. Neuronal Deposition of Amyloid-β Oligomers and Hyperphosphorylated Tau Is Closely Connected with Cognitive Dysfunction in Aged Dogs

    Article • Journal of Alzheimer s Disease Reports, October 2021, IOS Press

    Umma Habiba, MOURAD TAYEBI

  6. Cross-Linking Cellular Prion Protein Induces Neuronal Type 2-Like Hypersensitivity

    Article • Frontiers in Immunology, July 2021, Frontiers

    MOURAD TAYEBI

  7. Detection of retinal and blood Aβ oligomers with nanobodies

    Article • Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring, January 2021, Wiley

    MOURAD TAYEBI

  8. Epitope-specific anti-PrP antibody toxicity: a comparative in-silico study of human and mouse prion proteins

    Article • Prion, January 2021, Taylor & Francis

    MOURAD TAYEBI

  9. Treatment of Microglia with Anti-PrP Antibodies Induces Neuronal Allergenicity

    Article • October 2020, Research Square

    MOURAD TAYEBI

  10. Age-Specific Retinal Immunodetection of Amyloid-β Oligomers

    Article • Journal of Alzheimer’s Disease, June 2020, IOS Press

    Umma Habiba, MOURAD TAYEBI

  11. Fibroblastic Subtype has a Favourable Prognosis in Appendicular Osteosarcoma of Dogs

    Article • Journal of Comparative Pathology, April 2020, Elsevier

    MOURAD TAYEBI

  12. Parathyroid hormone receptor 1 (PTHR1) is a prognostic indicator in canine osteosarcoma

    Article • Scientific Reports, January 2020, Springer Science + Business Media

    MOURAD TAYEBI

  13. Treatment of Microglia with Anti-PrP Monoclonal Antibodies Induces Neuronal Apoptosis in Vitro

    Article • SSRN Electronic Journal, January 2020, Elsevier

    MOURAD TAYEBI

  14. Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos

    Article • Scientific Reports, November 2019, Springer Science + Business Media

    Umma Habiba, MOURAD TAYEBI

  15. Large expert-curated database for benchmarking document

    Article • Database, January 2019, Oxford University Press (OUP)

    Dr Daniel Prieto, Associate Professor James A.L. Brown, Professor Amanda G Thrift, Docent Kutty Selva Nandakumar, Professor Miguel Viveiros, MD Diego A. Valera-Cornejo, Dr Soroush Safaei, Dr Carmen San Martín, Piero Carninci, Dr Florian Rehfeldt, Dr Yoichi Watanabe, Kazuki Ide, Mr Alvin Wong, PD Dr. Adrian Meule, Dr Maurizio Petrelli, Dr Christine McGarrigle, Dr Tristan Reddan, Dr Nicola Roberts, Professor Stefan Lorkowski, Dr Cyrille Goarant, Dr Emma C Hobbs, Dr. Saurab Sharma, Ph.D., Dr Farid Rahimi, Prof. Iseult Lynch, Mirella Walker, Dr Luca Galluzzi, Sophie Ohlsson, Professor Tullio Florio, Dr Rabea A Gadelkareem, Dr Azubuike Christian Ukubuiwe, Prof Gajendra PS Raghava, Prof Jun Shen, Lubna Razak, ABHISHEKA BANSAL, Craig Billington, Dr Alejandro Lazo-Langner, Joan Albiol, MOURAD TAYEBI, Chuang Ma, Christine Toelzer , Dr. Kathrin Karsay, Professor Andrew M Beale, Professor Hugh James Byrne, Dr Ugo Marzocchi, Ana Nordberg, Martin Bartas, Natalia Echeverría, Dr Patricia M Graves

  16. A Comparative Review of Mixed Mammary Tumors in Mammals

    Article • Journal of Mammary Gland Biology and Neoplasia, November 2018, Springer Science + Business Media

    MOURAD TAYEBI

  17. Immunoinformatics Approach for Epitope-Based Peptide Vaccine Design and Active Site Prediction against Polyprotein of Emerging Oropouche Virus

    Article • Journal of Immunology Research, October 2018, Hindawi Publishing Corporation

    Utpal Kumar Adhikari, MOURAD TAYEBI

  18. An Aged Canid with Behavioral Deficits Exhibits Blood and Cerebrospinal Fluid Amyloid Beta Oligomers

    Article • Frontiers in Aging Neuroscience, January 2018, Frontiers

    Dr Kiterie ME Faller, Dr. Rita Guerreiro, MOURAD TAYEBI

  19. Immunohistochemical Validation of Spontaneously Arising Canine Osteosarcoma as a Model for Human Osteosarcoma

    Article • Journal of Comparative Pathology, November 2017, Elsevier

    MOURAD TAYEBI

  20. Canine Mixed Mammary Tumour as a Model for Human Breast Cancer with Osseous Metaplasia

    Article • Journal of Comparative Pathology, May 2017, Elsevier

    MOURAD TAYEBI

  21. Detection of Protein Aggregates in Brain and Cerebrospinal Fluid Derived from Multiple Sclerosis Patients

    Article • Frontiers in Neurology, December 2014, Frontiers

    MOURAD TAYEBI

  22. Potential candidate camelid antibodies for the treatment of protein-misfolding diseases

    Article • Journal of Neuroimmunology, July 2014, Elsevier

    MOURAD TAYEBI

  23. PrPSc-Specific Antibodies with the Ability to Immunodetect Prion Oligomers

    Article • PLOS One, May 2011, PLOS

    MOURAD TAYEBI

  24. PrP-specific camel antibodies with the ability to immunodetect intracellular prion protein

    Article • Journal of General Virology, March 2011, Society for General Microbiology

    MOURAD TAYEBI

  25. Epitope-specific anti-prion antibodies upregulate apolipoprotein E and disrupt membrane cholesterol homeostasis

    Article • Journal of General Virology, August 2010, Society for General Microbiology

    MOURAD TAYEBI

  26. PrP-specific camel antibodies with the ability to immunodetect intracellular prion protein

    Article • Journal of General Virology, August 2010, Society for General Microbiology

    MOURAD TAYEBI

  27. Glycosylphosphatidylinositol Anchor Analogues Sequester Cholesterol and Reduce Prion Formation

    Article • Journal of Biological Chemistry, July 2010, Elsevier

    MOURAD TAYEBI

  28. A glycosylphosphatidylinositol analogue reduced prion-derived peptide mediated activation of cytoplasmic phospholipase A2, synapse degeneration and neuronal death

    Article • Neuropharmacology, July 2010, Elsevier

    MOURAD TAYEBI

  29. The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication

    Article • Biochemical Journal, April 2010, Portland Press Ltd.

    MOURAD TAYEBI

  30. A Camelid Anti-PrP Antibody Abrogates PrPSc Replication in Prion-Permissive Neuroblastoma Cell Lines

    Article • PLOS One, March 2010, PLOS

    MOURAD TAYEBI

  31. Phospholipase A2 inhibitors protect against prion and Aβ mediated synapse degeneration

    Article • Molecular Neurodegeneration, January 2010, Springer Science + Business Media

    MOURAD TAYEBI

  32. Glimepiride Reduces the Expression of PrPC, Prevents PrPSc Formation and Protects against Prion Mediated Neurotoxicity

    Article • PLOS One, December 2009, PLOS

    MOURAD TAYEBI

  33. Polyunsaturated Fatty Acids Protect Against Prion-Mediated Synapse Damage In Vitro

    Article • Neurotoxicity Research, July 2009, Springer Science + Business Media

    MOURAD TAYEBI

  34. Unswitched immunoglobulin M response prolongs mouse survival in prion disease

    Article • Journal of General Virology, March 2009, Society for General Microbiology

    MOURAD TAYEBI

  35. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells

    Article • BMC Biology, September 2008, Springer Science + Business Media

    MOURAD TAYEBI

  36. Cholesterol esterification reduces the neurotoxicity of prions

    Article • Neuropharmacology, June 2008, Elsevier

    MOURAD TAYEBI

  37. Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2activation

    Article • BMC Biology, February 2008, Springer Science + Business Media

    MOURAD TAYEBI

  38. Ginkgolides protect against amyloid-β1–42-mediated synapse damage in vitro

    Article • Molecular Neurodegeneration, January 2008, Springer Science + Business Media

    MOURAD TAYEBI

  39. A role for B lymphocytes in anti-infective prion therapies?

    Article • Expert Review of Anti-infective Therapy, August 2007, Taylor & Francis

    MOURAD TAYEBI

  40. Antibody-mediated neuronal apoptosis: Therapeutic implications for prion diseases

    Article • Immunology Letters, June 2006, Elsevier

    MOURAD TAYEBI

  41. Protein Conformation Significantly Influences Immune Responses to Prion Protein

    Article • The Journal of Immunology, March 2005, The American Association of Immunologists

    MOURAD TAYEBI

  42. Disease-Associated Prion Protein Elicits Immunoglobulin M Responses In Vivo

    Article • Extremophiles, July 2004, Springer Science + Business Media

    MOURAD TAYEBI

  43. PrPSc Binding Antibodies Are Potent Inhibitors of Prion Replication in Cell Lines

    Article • Journal of Biological Chemistry, May 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Vincent Beringue, MOURAD TAYEBI

  44. Regional heterogeneity of cellular prion protein isoforms in the mouse brain

    Article • Brain, September 2003, Oxford University Press (OUP)

    Dr Vincent Beringue, MOURAD TAYEBI

  45. Monoclonal antibodies inhibit prion replication and delay the development of prion disease

    Article • Nature, March 2003, Springer Science + Business Media

    MOURAD TAYEBI